Evidence map›Paper›PMID 42859347›Full record

ArticleProbiotics and antimicrobial proteins2026

A Novel Cationic Antimicrobial Peptide Scymidgutin

Chang Zhang, Xianxian Dong, Ning Ding, Fangyi Chen, Ke-Jian Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chang ZhangState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, Fujian, 361102, China.
Xianxian DongState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, Fujian, 361102, China.
Ning DingState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, Fujian, 361102, China.
Fangyi ChenState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, Fujian, 361102, China. chenfangyi@xmu.edu.cn.ORCID https://orcid.org/0000-0001-5714-1339
Ke-Jian WangState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, Fujian, 361102, China. wkjian@xmu.edu.cn.

Funding

Fujian Ocean and Fisheries Bureau FJHYF-L-2025-13Fujian Province Industry-Academia Collaboration Project 2025N5001National Natural Science Foundation of China 42376089Pingtan Research Institute of Xiamen University Z20220743Xiamen Ocean Development Bureau 22CZP002HJ08
6 · The paper itself

Abstract

Marine-derived antimicrobial peptides possess both antibacterial and immunomodulatory activities, offering potential advantages for treating complex inflammatory conditions. Meanwhile, the management of inflammatory bowel disease is complicated by the interplay of microbial dysbiosis and bacterial-driven inflammation, which conventional single-target therapies frequently fail to address. In this study, we identified a novel cationic antimicrobial peptide, Scymidgutin

Indexed as

DSS-induced colitisMacrophage polarizationMarine antimicrobial peptideMembrane disruptionScymidgutin8−29

Identifiers

PMID42859347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.